Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFα biologics in rheumatic diseases. [electronic resource]
Producer: 20140506Description: 1429-35 p. digitalISSN:- 1434-9949
- Adalimumab
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antibodies, Neutralizing -- chemistry
- Arthritis, Psoriatic -- blood
- Arthritis, Rheumatoid -- blood
- Biological Products -- therapeutic use
- China
- Etanercept
- Female
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- Male
- Middle Aged
- Prognosis
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Rheumatic Diseases -- blood
- Sex Factors
- Spondylarthritis -- blood
- Time Factors
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- chemistry
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.